Page last updated: 2024-10-25

ciprofloxacin and Anti-Phospholipid Antibody Syndrome

ciprofloxacin has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"A decrease in the incidence of pregnancy loss and an improvement in the clinical manifestations of APS were noted in the mice treated with ciprofloxacin, compared with the mice given ceftazidime."7.70Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. ( Barak, V; Blank, M; Fishman, P; George, J; Koike, T; Levy, Y; Savion, S; Shoenfeld, Y; Toder, V, 1998)
"A decrease in the incidence of pregnancy loss and an improvement in the clinical manifestations of APS were noted in the mice treated with ciprofloxacin, compared with the mice given ceftazidime."3.70Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. ( Barak, V; Blank, M; Fishman, P; George, J; Koike, T; Levy, Y; Savion, S; Shoenfeld, Y; Toder, V, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blank, M1
George, J1
Fishman, P1
Levy, Y1
Toder, V1
Savion, S1
Barak, V1
Koike, T1
Shoenfeld, Y1

Other Studies

1 other study available for ciprofloxacin and Anti-Phospholipid Antibody Syndrome

ArticleYear
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression.
    Arthritis and rheumatism, 1998, Volume: 41, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Antibody Formation; Antiphospholipid Syndrom

1998